Ocugold is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Ajanta Pharma Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Chlorpheniramine Maleate, Beta Carotene,Lutein,Zexanthin. This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 96 (arround $1.344 US Dollar)
The main active ingredients or salts in Ocugold are :
Chlorpheniramine Maleate-100 mg
Lutein-3 mg
Zexanthin-3 mg
Beta Carotene-1.2 mg
Chlorpheniramine Maleate Indication (Prescribed for or used as): Allergic conditions. Adjunct in the emergency treatment of anaphylactic shock.
For more details on Chlorpheniramine Maleate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Chlorpheniramine Maleate..
Beta Carotene Indication (Prescribed for or used as):
For more details on Beta Carotene, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Beta Carotene..
Lutein Indication (Prescribed for or used as):
For more details on Lutein, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Lutein..
Zexanthin Indication (Prescribed for or used as):
For more details on Zexanthin, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Zexanthin..
Ocugold Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Ocugold, which have same Fixed-Dose Combination of active substances or ingredients (i.e. Chlorpheniramine Maleate-100 mg Lutein-3 mg Zexanthin-3 mg Beta Carotene-1.2 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.